Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)
Clinical trial NCT04502433 · TERMINATED
Trial details
- NCT number
- NCT04502433
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-06
- Primary completion
- 2022-03-17
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.